EW:NYSE
Edwards Lifesciences Corp
$85.13
arrow_upward
+1.06%(+0.89) 1D
Oct 9, 9:41:05 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$84.60
High
$85.31
Low
$84.53
Mkt. cap
49.07B
Avg. vol.
3.43M
Volume
71.58K
P/E ratio
49.25
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
Open
$84.60
High
$85.31
Low
$84.53
Mkt. cap
49.07B
Avg. vol.
3.43M
Volume
71.58K
P/E ratio
49.25
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
News stories
From web sources and news partners
Investing.com Nigeria
·
8 hours ago
Form 4 Edwards Lifesciences Corp For: 9 October By Investing.com
Investing.com
·
9 hours ago
Edwards Lifesciences CVP Daniel Lippis sells $53k in stock
MarketBeat
·
14 hours ago
Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares of Stock
News Corp
·
17 hours ago
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com